Eleva Reaches Industrial Production Scale and Prepares for Clinical Development of Factor H
Eleva, a manufacturer of superior biologics, is scaling up its production capacity to 2500 l in state-of-the-art single-use reactors. This will produce enough factor H to cover all three clinical phases.
- 14.09.2021, 10:30
- Kategoria: Nauka i technologie
- Źródło: APA-OTS